The purpose of this study is to create a registry to provide insight into treatment selection and treatment outcome of pancreatic IRE in order to develop an evidence base such that physicians can provide the best possible care to patients with pancreatic cancer requiring surgical interventions. The investigators seek a better understanding of the uses of ablation in the treatment of unresectable soft tissue pancreatic tumors and the limitations, concerns and complications that earlier users have.
Pancreatic Cancer
The purpose of this study is to create a registry to provide insight into treatment selection and treatment outcome of pancreatic IRE in order to develop an evidence base such that physicians can provide the best possible care to patients with pancreatic cancer requiring surgical interventions. The investigators seek a better understanding of the uses of ablation in the treatment of unresectable soft tissue pancreatic tumors and the limitations, concerns and complications that earlier users have.
American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry
-
University of Alabama Birmingham, Birmingham, Alabama, United States, 35233
University of California San Diego, San Diego, California, United States, 92093
University of Colorado, Denver, Colorado, United States, 80309
University of South Florida, Tampa, Florida, United States, 33620
Augusta University, Augusta, Georgia, United States, 30912
University of Louisville, Louisville, Kentucky, United States, 40202
Johns Hopkins Hospital, Baltimore, Maryland, United States, 21218
Atlantic Health, Millburn, New Jersey, United States, 07041
Northwell Health Cancer Institute, Lake Success, New York, United States, 11042
Gibbs Cancer Research, Spartanburg Regional Healthcare System, Spartanburg, South Carolina, United States, 29303
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to
ALL
No
University of Louisville,
Robert Martin, MD, PhD, PRINCIPAL_INVESTIGATOR, University of Louisville
2030-01